ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Interventional Pain Medicine

Top Interventional Pain Medicine Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN PARK MD

Interventional Pain Medicine

5,345

$885K

452
146 are 65+

76%
patients receiving schedule two controlled substances

Avg: 46%

13%
patients receiving schedule three controlled substances

Avg: 17%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 27%

$166
Average prescription price

Avg: $129

DENISE SCARINGE-DIETRICH M.D.

Interventional Pain Medicine

1,507

$120K

188
91 are 65+

39%
patients receiving schedule two controlled substances

Avg: 46%

19%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $129

ANDREW KAUFMAN M.D.

Interventional Pain Medicine

1,416

$168K

216
133 are 65+

45%
patients receiving schedule two controlled substances

Avg: 46%

6%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 27%

$119
Average prescription price

Avg: $129

MATTHEW LIPP MD

Interventional Pain Medicine

1,358

$149K

186
135 are 65+

54%
patients receiving schedule two controlled substances

Avg: 46%

20%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 27%

$110
Average prescription price

Avg: $129

CARMEN QUINONES M.D.

Interventional Pain Medicine

1,332

$128K

274
137 are 65+

67%
patients receiving schedule two controlled substances

Avg: 46%

20%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 27%

$96
Average prescription price

Avg: $129

VIVEK DAS M.D.

Interventional Pain Medicine

1,314

$286K

121
55 are 65+

79%
patients receiving schedule two controlled substances

Avg: 46%

23%
patients receiving schedule three controlled substances

Avg: 17%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 27%

$217
Average prescription price

Avg: $129

MOHSEN KALLINY M.D.

Interventional Pain Medicine

1,060

$148K

170
61 are 65+

69%
patients receiving schedule two controlled substances

Avg: 46%

22%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 27%

$139
Average prescription price

Avg: $129

THOMAS RAGUKONIS M.D.

Interventional Pain Medicine

1,031

$54.6K

131
57 are 65+

44%
patients receiving schedule two controlled substances

Avg: 46%

27%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

12%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $129

MAHER IBRAHIM MD

Interventional Pain Medicine

988

$56K

99
33 are 65+

45%
patients receiving schedule two controlled substances

Avg: 46%

21%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $129

UDAY BHATT M.D.

Interventional Pain Medicine

690

$55.8K

130
99 are 65+

43%
patients receiving schedule two controlled substances

Avg: 46%

16%
patients receiving schedule three controlled substances

Avg: 17%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 27%

$81
Average prescription price

Avg: $129

MICHAEL O'HARA D.O.

Interventional Pain Medicine

689

$118K

163
106 are 65+

45%
patients receiving schedule two controlled substances

Avg: 46%

15%
patients receiving schedule three controlled substances

Avg: 17%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

35%
prescriptions for brand name drugs

Avg: 27%

$171
Average prescription price

Avg: $129

SERGE MENKIN M.D.

Interventional Pain Medicine

555

$70.6K

79
21 are 65+

56%
patients receiving schedule two controlled substances

Avg: 46%

18%
patients receiving schedule three controlled substances

Avg: 17%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 27%

$127
Average prescription price

Avg: $129

JOHN MAK M.D.

Interventional Pain Medicine

495

$69.2K

154
116 are 65+

49%
patients receiving schedule two controlled substances

Avg: 46%

14%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

43%
prescriptions for brand name drugs

Avg: 27%

$140
Average prescription price

Avg: $129

RICHARD KANG MD

Interventional Pain Medicine

494

$42.1K

85
63 are 65+

35%
patients receiving schedule two controlled substances

Avg: 46%

26%
patients receiving schedule three controlled substances

Avg: 17%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 27%

$85
Average prescription price

Avg: $129

KENNETH ROGERS DO

Interventional Pain Medicine

486

$60.2K

148
82 are 65+

45%
patients receiving schedule two controlled substances

Avg: 46%

47%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 27%

$124
Average prescription price

Avg: $129

MARIA MOLINA MD

Interventional Pain Medicine

457

$103K

27
15 are 65+

41%
patients receiving schedule two controlled substances

Avg: 46%

0%
patients receiving schedule three controlled substances

Avg: 17%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 27%

$226
Average prescription price

Avg: $129

AJAY VARMA M.B. CH.B

Interventional Pain Medicine

451

$30.8K

60
29 are 65+

57%
patients receiving schedule two controlled substances

Avg: 46%

0%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $129

YASER MELIES M.D

Interventional Pain Medicine

445

$85.3K

78
11 are 65+

73%
patients receiving schedule two controlled substances

Avg: 46%

0%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 27%

$192
Average prescription price

Avg: $129

MARIAM GHOBRIEL M.D.

Interventional Pain Medicine

392

$27.8K

85
60 are 65+

35%
patients receiving schedule two controlled substances

Avg: 46%

20%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $129

MICHAEL AMOROSO M.D.

Interventional Pain Medicine

335

$43.4K

90
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 46%

23%
patients receiving schedule three controlled substances

Avg: 17%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 27%

$130
Average prescription price

Avg: $129

MICHAEL PALMER MD

Interventional Pain Medicine

323

$32K

81
70 are 65+

16%
patients receiving schedule two controlled substances

Avg: 46%

0%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

37%
prescriptions for brand name drugs

Avg: 27%

$99
Average prescription price

Avg: $129

CHANG KANG MD

Interventional Pain Medicine

319

$37.2K

64
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 46%

30%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

48%
prescriptions for brand name drugs

Avg: 27%

$117
Average prescription price

Avg: $129

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank